Table 2 Incidence of morbidity due to CanL, before and after the use of DMC
From: A twenty-year follow-up of canine leishmaniosis in three military kennels in southeastern France
Locations | Number of dogs | Symptomatic dogs | p-value | Power of the test | |
|---|---|---|---|---|---|
1993-2001 | 2002-2012 | (α = 0.05) | |||
Toulon/Hyères | 46 | 10 (21.7%) | 0 (0%) | < 0.001 | 92% |
Solenzara | 34 | 7 (20.5%) | 2 (5.9%) | > 0.05 | 40% |
Total | 80 | 17 (21.2%) | 2 (2.5%) | < 0.0001 | 97% |